Srikar Chem & Pharma India Private Limited

Srikar Chem & Pharma India Private Limited

Manufactures bulk drugs and intermediates, established in 2011, based in Telangana.
2011 | Hyderabad, Telangana (India) | Active

Last Updated:

December 14, 2024
HomeCompanySrikar Chem & Pharma India Private Limited

Who are the key members and board of directors at Srikar Chem & Pharma India?

Board Members(2)

NameDesignationAppointment DateStatus
Narravula Anuradha In Director 20-Nov-2019Current
Geyana Narravula In Director 20-Nov-2019Current

Financial Performance of Srikar Chem & Pharma India.

Srikar Chem & Pharma India Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 66.44% increase. The company also saw a substantial improvement in profitability, with a 211.34% increase in profit. The company's net worth Soared by an impressive increase of 268.7%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
66.44%
Revenue from Operations
66.44%
Total Assets
29.64%
Profit or Loss
211.34%
Net Worth
268.70%
EBITDA
453.63%

Charges (Loans)

Charges

There are no open charges registered against the company as per our records.

How Many Employees Work at Srikar Chem & Pharma India?

Srikar Chem & Pharma India has a workforce of 28 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Srikar Chem & Pharma India

Recent activity within the organization

  • Annual General Meeting

    Srikar Chem & Pharma India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Srikar Chem & Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.

    31 Mar 2024

  • Director Appointment

    Narravula Anuradha was appointed as a Director was appointed as a Director on 20 Nov 2019 & has been associated with this company since 5 years 1 month .

    20 Nov 2019

  • Director Appointment

    Geyana Narravula was appointed as a Director was appointed as a Director on 20 Nov 2019 & has been associated with this company since 5 years 1 month .

    20 Nov 2019

  • Company Incorporation

    Srikar Chem & Pharma India Private Limited was registered on 01 Feb 2011 with Roc Hyderabad & aged 13 years 10 months as per MCA records.

    01 Feb 2011

Frequently asked questions

  • Srikar Chem & Pharma India Private Limited was incorporated on 01 Feb 2011.

  • The authorized share capital of Srikar Chem & Pharma India Private Limited is ₹ 3.00 Cr and paid-up capital is ₹ 1.46 Cr.

  • Currently 2 directors are associated with Srikar Chem & Pharma India Private Limited.

    • Narravula Anuradha
    • Geyana Narravula
  • As per Ministry of Corporate Affairs (Mca), the registered address of Srikar Chem & Pharma India Private Limited is Dno:2-133/2 Flat No:215 Nirmal Ratna Apartments Gangaram, Chandanagar India, Hyderabad, Telangana, 500050.

  • The corporate identification number (CIN) of Srikar Chem & Pharma India Private Limited is U24100TG2011PTC072439 and the company number is 072439 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2020, the revenue trend for Srikar Chem & Pharma India Private Limited has risen by 66.44%.

  • As Per 2020 financial reports, 28 employees are currently employed by Srikar Chem & Pharma India Private Limited.

  • The financial reports for the fiscal year 2020 indicates that The net worth of Srikar Chem & Pharma India Private Limited has experienced an upsurge of 268.70%.

  • The most recent Balance Sheet for Srikar Chem & Pharma India Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development